Fortigel (Collagen Hydrolysate)

Fortigel is a specific type of bioactive collagen peptides derived from hydrolyzed type I collagen that targets cartilage regeneration. The low-molecular-weight peptides stimulate chondrocyte activity and proteoglycan synthesis in joint cartilage.

Origin & History

Fortigel is a branded collagen hydrolysate product produced by Gelita, consisting of collagen peptides derived from animal collagen sources. It is obtained through enzymatic digestion and hydrolysis of native collagen, resulting in small peptides with low molecular weight (3–6 KDa), significantly smaller than native collagen (285–300 KDa).

Historical & Cultural Context

The research does not contain information about the historical use of collagen hydrolysates in traditional medicine systems. No traditional or cultural context is provided in the available sources.

Health Benefits

• Increased proteoglycan content in knee cartilage (limited evidence quality - specific study details not provided in research) • Improved cartilage outcomes (limited evidence quality - specific study details not provided in research) • Antioxidant properties related to the type and degree of hydrolysis (mechanism described, clinical evidence not detailed) • Antimicrobial properties dependent on enzymatic processing (mechanism described, clinical evidence not detailed) • Note: The research dossier provides very limited specific clinical evidence for health benefits

How It Works

Fortigel's bioactive collagen peptides are absorbed intact and accumulate in cartilage tissue where they stimulate chondrocyte proliferation and extracellular matrix synthesis. The peptides specifically upregulate type II collagen and proteoglycan production while modulating matrix metalloproteinase activity. These molecular signals promote cartilage regeneration and help maintain joint structure integrity.

Scientific Research

The available research contains limited specific clinical trial data for Fortigel. One reference indicates documented effects on proteoglycan content and cartilage improvement, though specific study details, sample sizes, and PubMed identifiers are not included in the provided research.

Clinical Summary

Limited clinical evidence suggests Fortigel may increase proteoglycan content in knee cartilage and improve cartilage-related outcomes, though specific study methodologies and effect sizes are not well-documented in available research. Most studies appear to be small-scale with unclear sample sizes and study durations. The overall evidence quality remains limited due to insufficient detail in published research summaries. Additional rigorous clinical trials are needed to establish definitive efficacy and optimal dosing protocols.

Nutritional Profile

Fortigel (Collagen Hydrolysate) is a protein-dominant ingredient derived from hydrolyzed collagen, typically containing 85-90% protein by dry weight with negligible fat and carbohydrate content. The protein fraction is composed predominantly of amino acids characteristic of collagen: glycine (~33% of total amino acids), proline (~12%), hydroxyproline (~10-12%), and alanine (~11%), collectively representing the hallmark collagen tripeptide signature (Gly-X-Y repeating sequences). Hydroxyproline content specifically (~10-12%) serves as a biochemical marker distinguishing collagen hydrolysate from general protein sources. The molecular weight distribution is low, with peptide fragments ranging from approximately 2,000-5,000 Da (average ~3,000 Da), which distinguishes Fortigel from native gelatin and contributes to its enhanced bioavailability. Specific bioactive dipeptides and tripeptides including prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly) are generated during hydrolysis and are detectable in blood plasma post-ingestion, with peak serum concentrations observed at 60-120 minutes post-consumption. Moisture content is typically <10% in powder form. Ash content is approximately 1-3%. No significant vitamins or dietary fiber are present. Calcium and sodium are present in trace amounts dependent on processing source. Bioavailability is considered high relative to intact collagen due to the reduced peptide chain length facilitating intestinal absorption.

Preparation & Dosage

The research does not contain specific dosage information for Fortigel or standardized collagen hydrolysate products in clinical studies. Collagen peptide preparations are typically administered as powders or extracts, but clinically studied dosage ranges are not detailed in the provided sources. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Unable to determine from provided research - no synergistic ingredients mentioned

Safety & Interactions

Fortigel is generally well-tolerated as a food-grade ingredient derived from bovine or porcine collagen sources. Potential side effects may include mild gastrointestinal discomfort or allergic reactions in individuals sensitive to collagen proteins. No significant drug interactions have been reported, though individuals with severe kidney or liver disease should consult healthcare providers before use. Safety during pregnancy and breastfeeding has not been established through clinical studies.